video of tirzepatide injection How Deep to Inject Tirzepatide: Proper Subcutaneous Technique Guide Injecting Tirzepatide Into Muscle: Risks

"With the portfolio with a diverse portfolio that Abbott has where we look at healthcare across the full spectrum from nutrition to diagnostics to treatment, I think that this then provides the company with an opportunity to further explore where we can bring value to patients that are using these drugs," Ford said

Across the PIONEER trials around 1523% of patients experienced nausea with orally administered semaglutide 14 mg, and approximately 715% of patients on 14 mg orally administered semaglutide discontinued the trial

In the SURMOUNT-1 trial, adults without diabetes on tirzepatide lost an average of 15-22% of body weight over 72 weeks, depending on dose

Renal eligibility criteria are reported as specified in the primary trial publications and protocols